← Evidence map

TrialHepatology (Baltimore, Md.)2021

The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH.

Rohit Loomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

63 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32794259